FDA Inspection 1206864 — Pacific BioLabs, Inc.
The FDA completed an inspection of Pacific BioLabs, Inc. on Jun 1, 2023 in Hercules, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 1, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hercules, CA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1105 | 21 CFR 211.22(d) | Procedures not in writing, fully followed |
| 2401 | 21 CFR 211.194(a)(4) | Complete Test Data |
| 3613 | 21 CFR 211.160(b)(4) | Establishment of calibration procedures |
| 4402 | 21 CFR 211.192 | Written record of investigation incomplete |